PHARM — Pharming NV Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for Pharming NV, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	192	207	213	168	179
Net Total Accounts Receivable
Net Total Receivables	27.6	25.3	42.6	50.2	54.7
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	249	278	316	278	299
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	33.2	39.1	33.5	24.1	24
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	397	426	463	400	500
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	46.8	59.7	78	73.8	116
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	204	221	244	179	223
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	193	205	219	221	277
Total Liabilities & Shareholders' Equity	397	426	463	400	500
Total Common Shares Outstanding